Cytokine storms: Systemic disasters of infectious diseases

Infectious Diseases in Clinical Practice

Volumn 18, Issue 3, 2010, Pages 188-192

  Nazinitsky, Allison ^a   Rosenthal, Kenneth S ^a  

^a NORTHEAST OHIO MEDICAL UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; ALPHA INTERFERON; BACTERIAL TOXIN; BETA INTERFERON; COMPLEMENT; CORTICOSTEROID; CYTOKINE RECEPTOR ANTAGONIST; DNA; GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 2; INTERLEUKIN 23; INTERLEUKIN 6; LYMPHOTOXIN; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN LIKE RECEPTOR; PROTEIN C; RNA; RNA HELICASE; SUPERANTIGEN; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1;

BACTERIAL CELL WALL; BACTERIAL INFECTION; CYTOKINE PRODUCTION; CYTOKINE STORM; DEATH; DENDRITIC CELL; FUNGAL CELL; HUMAN; INFLUENZA VIRUS; INNATE IMMUNITY; MACROPHAGE; MYCOSIS; REVIEW; SARS CORONAVIRUS; SEPSIS; SHOCK; T LYMPHOCYTE; VIRUS INFECTION;

EID: 77952410070     PISSN: 10569103     EISSN: None     Source Type: Journal    
DOI: 10.1097/IPC.0b013e3181d2ee41     Document Type: Review

References (32)

1. Clark I. The advent of the cytokine storm. Immunol Cell Biol. 2007;85:271-273.
2. Case definitions for public health surveillance. MMWR. 1990;39(RR-13): 1-43.
3. Janssens S, Beyaert R. Role of Toll-like receptors in pathogen recognition. Clin Microbiol Rev. 2003;16:637-646.
4. Cinel I, Opal SM. Molecular biology of inflammation and sepsis; a primer: pattern recognition receptors, pathogen-associated molecular patterns (PAMPs) and danger-associated molecular patterns (DAMPs). Crit Care Med. 2009;37:291-304.
5. Hellerud BC, Stenvikm J, Espevik T, et al. Stages of meningococcal sepsis simulated in vitro, with emphasis on complement and Toll-like receptor activation. Infect Immun. 2008;76:4183-4189.
6. Markiewski MM, Nilsson B, Ekdah KN, et al. Complement and coagulation: strangers or partners in crime? Trends Immunol. 2007;28:184-192.
7. Doherty PC, Turner SJ, Webby RG, et al. Influenza and the challenge of immunology. Nature Immunology. 2006;7:449-455.
8. Cheung CY, Poon L L M, Lau AS, et al. Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease? Lancet. 2002;360:1831-1837.
9. Szretter KJ, Gangappa S, Lu X, et al. Role of host cytokine responses in the pathogenesis of avian H5N1 infleunza viruses in mice. J Virol. 2007;81:2736-2744.
10. Huang S-J, Su I-J, Theron M, et al. An interferon gamma related cytokine storm in SARS patients. J Med Virol. 2004;75:185-194.
11. McKenna K, Beignon A-S, Bhardwaj N. Plasmacytoid dendritic cells: linking innate and adaptive immunity. J Virol. 2005;79:17-27.
12. Osterholm MT. Proposed mechanism of the cytokine storm evoked by influenza virus. N Engl J Med. 2005;352(18):1839-1842.
13. Proft T, Fraser JD. Bacterial superantigens. Clin Exp Immunol. 2003;133:299-306.
14. Baker MD, Acharya KR. Superantigens: structure-function relationships. Int J Med Microbiol. 2004;293:529-537.
15. Llewelyn M, Cohen J. Superantigens: microbial agents that corrupt immunity. Lancet Infect Dis. 2002;2:156-162.
16. Hsiao FC, Lin M, Tai A, et al. Cutting edge Epstein-Barr virus transactivates the HERV-K18 superantigen by docking to the human complement receptor 2 (CD21) on primary B cells. J Immunol. 2006;177:2056-2060.
17. Sriskandan S, Altmann DM. The immunology of sepsis. J Pathol. 2008;214:211-223.
18. Adib-Conquy M, Cavaillon J-M. Stress molecules in sepsis and systemic inflammatory response syndrome. FEBS Lett. 2007;581:3723-3733.
19. Hoesel LM, Gao H, Ward PA. New insights into cellular mechanisms during sepsis. Immunol Res. 2006;34:133-141.
20. Blackwell TS, Christman JW. Sepsis and cytokines: current status. Br J Anaesth. 1996;77:110-117.
21. Cavaillon JM, Adib-Conquy M, Fitting C, et al. Cytokine cascade in sepsis. Scand J Infect Dis. 2003;35:535-544.
22. Cavaillon J-M, Annane D. Compartmentalization of the inflammatory response in sepsis and SIRS. J Endotoxin Res. 2006;12:151-170.
23. Martinez GJ, Nurieva RI, Yang XO, et al. Regulation and function of proinflammatory TH17 cells. Ann N Y Acad Sci. 2008;1143:188-211.
24. Kikly K, Liu L, Na S, et al. The IL-23/Th (17) axis: therapeutic targets for autoimmune inflammation. Curr Opin Immunol. 2006;18:670-675.
25. Sprong T, Muller AS, Bjerre A, et al. Complement activation and complement-dependent inflammation by Neisseria meningitidis are independent of lipopolysaccharide. Infect Immun. 2004;72:3344-3349.
26. Jackson CJ, Xue M. Activated protein C - an anticoagulant that does more than stop clots. Int J Biochem Cell Biol. 2008;40(12):2692-2697.
27. Levings MK, Bacchetta R, Schulz U, et al. The role of IL-10 and TGF-beta in the differentiation and effector function of T regulatory cells. Int Arch Allergy Immunol. 2003;129:263-276.
28. Suntharalingam G, Perry MR, Ward S, et al. Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412. N Engl J Med. 2006;355:1018-1028.
29. Aldridge JR, Moseley CE, Boltz DA, et al. TNF/iNOS-producing dendritic cells are the necessary evil of lethal influenza virus infection. Proc Natl Acad Sci U S A. 2009;106:5306-5311.
30. Dellinger RP, Cinel I, Sharma S, et al. Septic Shock. 2009. Available at: http://emedicine.medscape.com/article/168402. Accessed September 15, 2009.
31. Taylor A, Verhagen J, Blaser K, et al. Mechanisms of immune suppression by interleukin-10 and transforming growth factor-beta: the role of T regulatory cells. Immunology. 2006;117:433-442.
32. Sharma S. Toxic Shock Syndrome: Treatment and Medication. 2009. Available at: http://emedicine.medscape.com/article/169177-treatment. Accessed September 15, 2009.